These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 7044387
1. [Inhibition of nocturnal acid secretion by pirenzepine (author's transl)]. Dammann HG, Simon B, Müller P, Krüger HJ. Arzneimittelforschung; 1982; 32(3):309-10. PubMed ID: 7044387 [Abstract] [Full Text] [Related]
2. Inhibition of pentagastrin and insulin-stimulated gastric secretion by pirenzepine in healthy and duodenal ulcer subjects. Bianchi Porro G, Prada A, Petrillo M, Grossi M. Scand J Gastroenterol Suppl; 1979; 57():63-7. PubMed ID: 396660 [Abstract] [Full Text] [Related]
3. [Effect of pirenzepine and atropine on the transmural gastric mucosal potential difference (author's transl)]. von Kleist D, Staud R, Stopik D, Hampel HE. Dtsch Z Verdau Stoffwechselkr; 1980; 40(3-4):110-4. PubMed ID: 6893819 [Abstract] [Full Text] [Related]
4. [Pirenzepine inhibits meal-induced secretory and gastrin responses in dogs (author's transl)]. Bonfils S, Vatier J, de Mestier P, Accary JP, Kuan T, Bourgeois M. Gastroenterol Clin Biol; 1982 Jan; 6(1):33-7. PubMed ID: 6896039 [No Abstract] [Full Text] [Related]
5. Inhibition of gastric acid secretion by pirenzepine (LS 519) in man. Stockbrügger R, Jaup B, Hammer R, Dotevall G. Scand J Gastroenterol; 1979 Jan; 14(5):615-20. PubMed ID: 493865 [Abstract] [Full Text] [Related]
6. Inhibition by pirenzepine of nocturnal gastric acid secretion in duodenal ulcer patients. Corinaldesi R, Miglioli M, Daniotti S, Stanghellini V, Borghi E, Barbara L. Scand J Gastroenterol; 1981 Jan; 16(7):929-31. PubMed ID: 6895676 [Abstract] [Full Text] [Related]
8. The effect of pirenzepine on basal, pentagastrin- and insulin-stimulated gastric acid secretion in patients with peptic ulcer disease. Jaup BH, Stockbrügger R, Dotevall G. Scand J Gastroenterol; 1979 Feb; 14(5):621-4. PubMed ID: 493866 [Abstract] [Full Text] [Related]
9. Therapeutic effect of pirenzepine dihydrochloride on gastric ulcer evaluated by a double-blind controlled clinical study. Phase III study. Ishimori A, Yamagata S. Arzneimittelforschung; 1982 Feb; 32(5):556-65. PubMed ID: 7049190 [Abstract] [Full Text] [Related]
11. Pirenzepine in the treatment of duodenal ulcer. D'Imperio N, Giuliani Piccari G, Lepore AM, Sarti F, Dal Monte PR. Scand J Gastroenterol Suppl; 1979 Feb; 57():41-4. PubMed ID: 396656 [Abstract] [Full Text] [Related]
12. The influence of various secretory inhibitors on peptic activity. Gabryelewicz A, Laszewicz W, Sarosiek J. Scand J Gastroenterol Suppl; 1980 Feb; 66():79-85. PubMed ID: 6264587 [Abstract] [Full Text] [Related]
13. Actions of pirenzepine-dihydrochloride (LS-519 Cl) on gastric juice secretion, gastric motility and experimental gastric ulcer. Matsuo Y, Seki A. Arzneimittelforschung; 1979 Feb; 29(7):1028-35. PubMed ID: 582994 [No Abstract] [Full Text] [Related]
14. Effect of pirenzepine, a new gastric acid-inhibiting agent, on exocrine pancreatic secretion in man. Brunner H, Veriá M, Polterauer P, Grabner G. Arzneimittelforschung; 1977 Feb; 27(3):684-7. PubMed ID: 577446 [Abstract] [Full Text] [Related]
15. [Acid secretion and serum gastrin during acute and chronic treatment with pirenzepine in duodenal ulcer (author's transl)]. Scholten T, Fritsch WP, Müller JE, Hanrath R, Strohmeyer G. Z Gastroenterol; 1981 Jul; 19(7):323-8. PubMed ID: 6895273 [Abstract] [Full Text] [Related]
16. [Effectiveness of cimetidine, pirenzepine and synthetic secretin on stimulated gastric acid secretion]. Londong W, Londong V, Prechtl R, Schwanner A. Z Gastroenterol; 1980 Jun; 18(6):306-13. PubMed ID: 6893378 [Abstract] [Full Text] [Related]
17. Postprandial pancreatic exocrine secretion in dogs after oral administration of pirenzepine dihydrochloride. Madrid JA, Salido GM, Martinez de Victoria E, Mañas M, Mataix FJ. Arzneimittelforschung; 1985 Jun; 35(10):1560-2. PubMed ID: 2416323 [Abstract] [Full Text] [Related]